At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions

Eli Lilly is set to increase the UK price of its weight-loss and diabetes drug Mounjaro by 170%, aligning it with other European markets. Originally underpriced for NHS accessibility, Mounjaro has now surpassed rival Wegovy in UK sales.

Investing.com -- Eli Lilly (NYSE:LLY) has increased the price of its weight loss drug Mounjaro in the United Kingdom by up to 170%, according to the Financial Times on Thursday. The pharmaceutical company’s price for a month’s supply of the highest doses of Mounjaro will rise from £122 to £330, the FT reported.